摘要
脊椎动物视网膜的结构和发育机制是高度保守的。在retinogenesis最有特色的活动之一是在时间和空间上的多能视网膜祖细胞七种类型的视网膜细胞的产生。通过基因表达和蛋白质功能的多样性调制的重要性以及在这一过程中调控SUMO化患病率已越来越欣赏。在这里,我们回顾在视网膜发育的SUMO化修饰的生物学意义,探讨SUMO化平衡和视网膜祖细胞退出细胞周期增殖的分子机制,并探讨通过多种转录因子调制调解不同视网膜神经元和光感受器的规范。在正常视网膜功能的SUMO化修饰的潜在作用是由SUMO化机械关键部件在小鼠视网膜的表达,也是以高度保守的SUMO化修饰位点对神经节细胞的神经递质受体为例。
关键词: 视网膜发育,SUMO化修饰,SUMO1 / 2 / 3,感光器规格,转录因子,神经递质。
Current Molecular Medicine
Title:SUMOylation Regulation of Retina Development and Functions
Volume: 16 Issue: 9
Author(s): L. Zhang, D. W.-C. Li
Affiliation:
关键词: 视网膜发育,SUMO化修饰,SUMO1 / 2 / 3,感光器规格,转录因子,神经递质。
摘要: The structure and developmental mechanisms of vertebrate retina are highly conserved. One of the most distinctive events during retinogenesis is the temporally and spatially generation of seven types of retinal cells from the multipotent retinal progenitor cells. The importance and prevalence of SUMOylation in regulation of this process through modulation of gene expression and protein function diversity have been increasingly appreciated. Here, we review the biological significance of SUMOylation in retina development, examine how SUMOylation balances the proliferation and cell cycle exit of retinal progenitor cells, and finally discuss the molecular mechanisms mediating the specification of different retina neurons and photoreceptors through modulation of various transcription factors. The potential role of SUMOylation in normal retina function is illustrated by the abundant expression of key components of SUMOylation machinery in mouse retina, and is also exemplified by the highly conserved SUMOylation site on neurotransmission receptors in ganglion cells.
Export Options
About this article
Cite this article as:
L. Zhang, D. W.-C. Li , SUMOylation Regulation of Retina Development and Functions, Current Molecular Medicine 2016; 16 (9) . https://dx.doi.org/10.2174/1566524016666161128115453
DOI https://dx.doi.org/10.2174/1566524016666161128115453 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Secondary Metabolites from Cordyceps Species and Their Antitumor Activity Studies
Recent Patents on Biotechnology Effects of Tyrosine Kinase Inhibitors on Growth and Bone Metabolism in Children with Haematologic Malignancies
Cardiovascular & Hematological Agents in Medicinal Chemistry Repositioning of DHFR Inhibitors
Current Topics in Medicinal Chemistry The 18 kDa Translocator Protein (TSPO): A New Perspective in Mitochondrial Biology
Current Molecular Medicine iPSCs Derived from Malignant Tumor Cells: Potential Application for Cancer Research
Current Stem Cell Research & Therapy The cytotoxic effect of GW843682X on nasopharyngeal carcinoma
Anti-Cancer Agents in Medicinal Chemistry Taking Risk Prediction to the Next Level. Advances in Biomarker Research for Atherosclerosis
Current Pharmaceutical Design Understanding XPO1 Target Networks Using Systems Biology and Mathematical Modeling
Current Pharmaceutical Design Advances in Research of Schiff-Base Metal Complexes as Potent Antioxidants
Current Medicinal Chemistry Role of Tyrosine Phosphatase Inhibitors in Cancer Treatment with Emphasis on SH2 Domain-Containing Tyrosine Phosphatases (SHPs)
Anti-Cancer Agents in Medicinal Chemistry Targeted Cancer Therapy: The Next Generation of Cancer Treatment
Current Drug Discovery Technologies Damage and Recovery of the Bone Marrow Microenvironment Induced by Cancer Chemotherapy – Potential Regulatory Role of Chemokine CXCL12/Receptor CXCR4 Signalling
Current Molecular Medicine Multi-Nuclear Platinum Drugs: A New Paradigm in Chemotherapy
Current Medicinal Chemistry - Anti-Cancer Agents Sporadic Porphyria in a Patient with Stage II Melanoma Treated with Interferon α
Current Drug Safety Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives From Preclinical and Clinical Studies
Current Drug Targets Cancer Therapy: Targeting Cell Cycle Regulators
Anti-Cancer Agents in Medicinal Chemistry Metabolomics Applications in Precision Medicine: An Oncological Perspective
Current Topics in Medicinal Chemistry Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis
Current Drug Metabolism Cancer and Stem Cells
Current Cancer Therapy Reviews Immunity to Tumour Antigens
Current Pharmaceutical Design